Renovaro Biosciences Inc (RENB) — Working Capital to Net Assets Ratio
Renovaro Biosciences Inc (RENB) has a Working Capital to Net Assets ratio of 131.7% as of June 2025. Working capital of $-28.11 Million (current assets of $1.05 Million minus current liabilities of $29.16 Million) is measured against net assets of $-21.35 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Renovaro Biosciences Inc net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Renovaro Biosciences Inc Working Capital to Net Assets (2012–2025)
This chart shows how Renovaro Biosciences Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2025, the ratio stands at 131.7%, reflecting working capital of $-28.11 Million against net assets of $-21.35 Million USD. Check RENB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Renovaro Biosciences Inc (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Renovaro Biosciences Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Renovaro Biosciences Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -21.5% | $-28.31 Million | $131.98 Million | $2.00 Million | $30.31 Million | ▲ +0.0 pp |
| 2024 | -21.5% | $-28.31 Million | $131.98 Million | $2.00 Million | $30.31 Million | ▼ -3.3 pp |
| 2023 | -18.2% | $-8.46 Million | $46.50 Million | $2.57 Million | $11.02 Million | ▼ -22.5 pp |
| 2022 | 4.3% | $3.11 Million | $72.62 Million | $9.57 Million | $6.45 Million | ▼ -6.6 pp |
| 2021 | 10.9% | $19.01 Million | $174.66 Million | $20.90 Million | $1.89 Million | ▲ +6.3 pp |
| 2020 | 4.6% | $7.61 Million | $166.27 Million | $8.94 Million | $1.33 Million | ▼ -2.0 pp |
| 2019 | 6.6% | $11.38 Million | $173.10 Million | $12.49 Million | $1.11 Million | ▼ -2.8 pp |
| 2018 | 9.4% | $14.89 Million | $158.74 Million | $15.76 Million | $873.72K | ▼ -69.5 pp |
| 2017 | 78.9% | $1.21 Million | $1.53 Million | $4.20 Million | $2.99 Million | ▼ -42.8 pp |
| 2016 | 121.7% | $-775.75K | $-637.40K | $732.48K | $1.51 Million | ▲ +27.3 pp |
| 2015 | 94.4% | $3.29 Million | $3.48 Million | $5.05 Million | $1.76 Million | ▼ -30.6 pp |
| 2014 | 125.0% | $-2.00 Million | $-1.60 Million | $100.00K | $2.10 Million | ▲ +25.0 pp |
| 2013 | 100.0% | $-51.27K | $-51.27K | $19.96K | $71.23K | ▲ +0.0 pp |
| 2012 | 100.0% | $-13.68K | $-13.68K | $13.55K | $27.23K | — |